Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Chemist license suspended for selling MTP pills sans prescription

      Chemist license suspended for selling MTP pills sans prescription

      Farhat Nasim28 Aug 2019 4:35 PM IST
      Indore: In a major crackdown, a chemist has been nabbed for selling abortion pills without medical prescription. The authority has suspended his...
      Unichem gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder

      Unichem gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder

      Farhat Nasim28 Aug 2019 2:39 PM IST
      Solifenacin Succinate Tablet is a generic version of Vesicare Tablets of Astellas Pharma US, Unichem said.New Delhi: Drug firm Unichem Laboratories...
      Purdue Pharma offers upto USD 12 billion to settle opioid claims

      Purdue Pharma offers upto USD 12 billion to settle opioid claims

      Farhat Nasim28 Aug 2019 9:00 AM IST
      U.S: OxyContin maker Purdue PharmaLP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the...
      Indian Stent Maker Translumina sells stake to PE Everstone for Rs 500 crore: Report

      Indian Stent Maker Translumina sells stake to PE Everstone for Rs 500 crore: Report

      Farhat Nasim27 Aug 2019 3:31 PM IST
      Mumbai: Cardiac stents and cardiovascular medical devices maker, Translumina Therapeutics is reported to have sold its minority stake to Private...
      Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

      Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

      Farhat Nasim27 Aug 2019 2:30 PM IST
      "Strides Pharma Inc has acquired the manufacturing facility under an asset purchase agreement with Micelle Biopharma Inc for a consideration of USD...
      Ghaziabad formulations facility gets 1 USFDA observation: Unichem Laboratories

      Ghaziabad formulations facility gets 1 USFDA observation: Unichem Laboratories

      Farhat Nasim26 Aug 2019 9:35 AM IST
      Unichem said it will provide the response and corrective action plan within the next 15 working days to address the USFDA observation for its...
      USFDA recalls Edwards Lifesciences heart valves delivery system linked to 1 death, 17 injuries

      USFDA recalls Edwards Lifesciences heart valves delivery system linked to 1 death, 17 injuries

      Farhat Nasim25 Aug 2019 9:55 AM IST
      The agency said balloons that have burst during implantation procedures resulted in significant difficulty in retrieving the valve into the catheter...
      NPPA fixes MRP of 2 combo drugs manufactured by Emcure, Hetero Labs to prevent HIV; Details

      NPPA fixes MRP of 2 combo drugs manufactured by Emcure, Hetero Labs to prevent HIV; Details

      Farhat Nasim24 Aug 2019 3:22 PM IST
      New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
      Glenmark gets USFDA nod for generic of Loestrin tablets to prevent pregnancy

      Glenmark gets USFDA nod for generic of Loestrin tablets to prevent pregnancy

      Farhat Nasim24 Aug 2019 11:45 AM IST
      "Glenmark Pharmaceuticals USA has been granted final approval by the US Food and Drug Administration (USFDA) for Hailey 24 Fe (Norethindrone Acetate...
      Faulty Hip Implants: JnJ pays Rs 25 lakh each to three victims in Uttar Pradesh

      Faulty Hip Implants: JnJ pays Rs 25 lakh each to three victims in Uttar Pradesh

      Farhat Nasim24 Aug 2019 10:56 AM IST
      According to Uttar Pradesh Drug Licensing and Control officer A K Jain, the company has given compensation to three patients who had undergone...
      Impact of Digital Health on Healthcare professionals: Key points from Phillips Future Health index 2019 Report

      Impact of Digital Health on Healthcare professionals: Key points from Phillips Future Health index 2019 Report

      Farhat Nasim22 Aug 2019 2:42 PM IST
      New Delhi: Royal Philips, recently unveiled the India findings of its 15-country Future Health Index (FHI) 2019 report, ‘Transforming healthcare...
      Much anticipated Medanta-Manipal deal comes to halt: Report

      Much anticipated Medanta-Manipal deal comes to halt: Report

      Farhat Nasim20 Aug 2019 1:49 PM IST
      Mumbai: The much anticipated Medanta-Manipal deal worth Rs 5800 crore has come to a halt. The deal failure is reportedly the result of valuation...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok